SG11201705450SA - Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases - Google Patents
Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseasesInfo
- Publication number
- SG11201705450SA SG11201705450SA SG11201705450SA SG11201705450SA SG11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA SG 11201705450S A SG11201705450S A SG 11201705450SA
- Authority
- SG
- Singapore
- Prior art keywords
- metabolic
- bacteria
- diseases
- compositions
- treating
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 230000002503 metabolic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15150701 | 2015-01-09 | ||
| PCT/EP2016/050310 WO2016110585A1 (en) | 2015-01-09 | 2016-01-08 | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705450SA true SG11201705450SA (en) | 2017-07-28 |
Family
ID=52434520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705450SA SG11201705450SA (en) | 2015-01-09 | 2016-01-08 | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11452746B2 (zh) |
| EP (1) | EP3242957B1 (zh) |
| KR (1) | KR20170103920A (zh) |
| CN (1) | CN107405369A (zh) |
| AU (1) | AU2016205975B2 (zh) |
| BR (1) | BR112017014649A2 (zh) |
| CA (1) | CA2973285C (zh) |
| DK (1) | DK3242957T3 (zh) |
| ES (1) | ES2796355T3 (zh) |
| PL (1) | PL3242957T3 (zh) |
| RU (1) | RU2017126666A (zh) |
| SG (1) | SG11201705450SA (zh) |
| WO (1) | WO2016110585A1 (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113730442A (zh) | 2014-10-31 | 2021-12-03 | 潘德勒姆治疗公司 | 与病症的微生物治疗和诊断有关的方法和组合物 |
| DK3242957T3 (da) | 2015-01-09 | 2020-06-02 | Univ Wageningen | Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme |
| US10857189B2 (en) | 2016-02-25 | 2020-12-08 | Caelus Pharmaceuticals B.V. | Compositions and methods for preventing and/or treating vitamin B12 deficiency |
| AU2018326705A1 (en) | 2017-08-30 | 2020-03-05 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
| WO2019113023A1 (en) * | 2017-12-04 | 2019-06-13 | The BioCollective, LLC | Probiotics and methods of use |
| FR3085963A1 (fr) * | 2018-09-19 | 2020-03-20 | Novolyze | Composition seche de microorganismes modeles |
| NL2024569B1 (en) * | 2019-12-24 | 2021-09-06 | Univ Wageningen | Bacterium comprising myo-inositol to propionate pathway |
| RU2734718C1 (ru) * | 2019-12-31 | 2020-10-22 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Способ уменьшения выраженности немоторных симптомов у пациентов, страдающих болезнью Паркинсона |
| NL2028324B1 (en) | 2021-05-28 | 2022-12-12 | Caelus Pharmaceuticals B V | Insulin-sensitizing agent and butyrate-producing bacterium |
| US20240197662A1 (en) * | 2021-12-20 | 2024-06-20 | Tainnovation Inc | Methods of and compositions for treating obesity, obesity-related diseases or cancers using a n6-methyllysine/l-lysine mixture |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005026452D1 (de) * | 2004-12-28 | 2011-03-31 | Meiji Seika Kaisha | Neuer, dem wirt gegen krankheiten gerichtete eigenschaften verleihender stamm und bakterienzellzusammensetzung |
| RU2613322C2 (ru) | 2011-08-30 | 2017-03-15 | Академис Медис Сентрум | Способ профилактики и/или лечения инсулинорезистентности |
| US20140242654A1 (en) | 2013-02-26 | 2014-08-28 | Coskata, Inc. | Butyrate Producing Clostridium species, Clostridium pharus |
| US9669059B2 (en) | 2013-03-15 | 2017-06-06 | University Of Florida Research Foundation, Incorporated | Butyrogenic bacteria as probiotics to treat clostridium difficile |
| DK3242957T3 (da) | 2015-01-09 | 2020-06-02 | Univ Wageningen | Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme |
-
2016
- 2016-01-08 DK DK16700202.1T patent/DK3242957T3/da active
- 2016-01-08 AU AU2016205975A patent/AU2016205975B2/en active Active
- 2016-01-08 PL PL16700202T patent/PL3242957T3/pl unknown
- 2016-01-08 WO PCT/EP2016/050310 patent/WO2016110585A1/en active Application Filing
- 2016-01-08 CN CN201680005423.XA patent/CN107405369A/zh active Pending
- 2016-01-08 KR KR1020177022306A patent/KR20170103920A/ko not_active Application Discontinuation
- 2016-01-08 CA CA2973285A patent/CA2973285C/en active Active
- 2016-01-08 ES ES16700202T patent/ES2796355T3/es active Active
- 2016-01-08 BR BR112017014649-5A patent/BR112017014649A2/pt not_active Application Discontinuation
- 2016-01-08 US US15/542,311 patent/US11452746B2/en active Active
- 2016-01-08 SG SG11201705450SA patent/SG11201705450SA/en unknown
- 2016-01-08 EP EP16700202.1A patent/EP3242957B1/en active Active
- 2016-01-08 RU RU2017126666A patent/RU2017126666A/ru not_active Application Discontinuation
-
2020
- 2020-09-23 US US17/030,196 patent/US11426436B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107405369A (zh) | 2017-11-28 |
| ES2796355T3 (es) | 2020-11-26 |
| AU2016205975B2 (en) | 2021-05-27 |
| US11426436B2 (en) | 2022-08-30 |
| EP3242957A1 (en) | 2017-11-15 |
| RU2017126666A3 (zh) | 2019-07-24 |
| WO2016110585A1 (en) | 2016-07-14 |
| US11452746B2 (en) | 2022-09-27 |
| CA2973285C (en) | 2023-10-17 |
| RU2017126666A (ru) | 2019-02-12 |
| PL3242957T3 (pl) | 2020-10-05 |
| US20180353552A1 (en) | 2018-12-13 |
| KR20170103920A (ko) | 2017-09-13 |
| US20210069263A1 (en) | 2021-03-11 |
| CA2973285A1 (en) | 2016-07-14 |
| CN107405369A8 (zh) | 2018-01-16 |
| AU2016205975A1 (en) | 2017-07-27 |
| DK3242957T3 (da) | 2020-06-02 |
| EP3242957B1 (en) | 2020-03-11 |
| BR112017014649A2 (pt) | 2018-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264049A (en) | Compounds, preparations and methods for treating the disease | |
| HK1258205A1 (zh) | 用於治療血紅蛋白病的組合物和方法 | |
| IL264156A (en) | Compounds, preparations and methods for treating the disease | |
| IL289099A (en) | Methods for storage of whole blood, and corresponding preparations | |
| HK1256726A1 (zh) | 載體結合劑組合物及其製備和使用方法 | |
| IL259246A (en) | Preparations containing pharmaceutical substances and methods of using them | |
| SG11201705450SA (en) | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases | |
| ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
| EP3408344A4 (en) | METHOD AND COMPOSITIONS FOR BORING TREATMENT | |
| PL3261726T3 (pl) | Kompozycja do leczenia trądziku | |
| HK1259372A1 (zh) | 治療化合物、其組合物及使用方法 | |
| EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
| EP3310376A4 (en) | MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF | |
| IL275182A (en) | Preparations and methods for the treatment of metabolic conditions | |
| IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
| HK1249515A1 (zh) | 預防和治療聽力損失的方法和組合物 | |
| ZA201902781B (en) | Compositions and methods for the treatment of xerostomia | |
| HK1247136A1 (zh) | 包含15-hepe的組合物和其使用方法 | |
| IL249640A0 (en) | Preparations for the treatment of nosebleeds | |
| IL248210A0 (en) | Methods and preparations for the treatment of blood vessel malformations | |
| EP3310377A4 (en) | Method of treating crohn's disease | |
| EP3341006A4 (en) | COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE | |
| HK1255695A1 (zh) | 用於治療眼瞼下垂的組合物和方法 | |
| HK1258999A1 (zh) | 用於治療肝臟和維持肝臟健康的組合物、方法和藥物組合物 | |
| HK1258765A1 (zh) | 治療性化合物、組合物和它們的使用方法 |